The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 4229-4246

  Gao, Hongjun ^b   Liu, Jinjian ^a   Yang, Cuihong ^a   Cheng, Tangjian ^b   Chu, Liping ^a   Xu, Hongyan ^a   Meng, Aimin ^a   Fan, Saijun ^a   Shi, Linqi ^b   Liu, Jianfeng ^a  

^a INSTITUTE OF RADIATION MEDICINE   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Drug delivery; In vivo biodistribution; Macrophage uptake; Mixed shell micelles; PEGylation

Indexed keywords

IODINE 125; MACROGOL; NANOCARRIER; TRACER;

ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HYDROPHILICITY; IN VIVO STUDY; ISOTOPE LABELING; LIGHT SCATTERING; MACROPHAGE; MALE; MICELLE; MOUSE; NONHUMAN; PROTEIN CONFORMATION; RETICULOENDOTHELIAL SYSTEM;

DRUG DELIVERY; IN VIVO BIODISTRIBUTION; MACROPHAGE UPTAKE; MIXED SHELL MICELLES; PEGYLATION;

ADSORPTION; ANALYSIS OF VARIANCE; ANIMALS; BLOOD PROTEINS; CELL SURVIVAL; DRUG CARRIERS; HEP G2 CELLS; HUMANS; IODINE RADIOISOTOPES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICELLES; MOLECULAR WEIGHT; NANOPARTICLES; NIH 3T3 CELLS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION;

EID: 84887385010     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S51566     Document Type: Article

References (32)

1. Nel AE, Mädler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8(7): 543-557.
2. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2): 283-318.
3. Chithrani BD, Ghazani AA, Chan W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6(4):662-668.
4. Zhang S, Li J, Lykotrafitis G, Bao G, Suresh S. Size-dependent endocytosis of nanoparticles. Adv Mater. 2009;21:419-424.
5. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9): 771-782.
6. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008;105(38):14265-14270.
7. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505-515.
8. Storm G, Belliot SO, Daemen T, Lasic DD. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Delivery Rev. 1995;17(1):31-48.
9. Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K. Long-circulating poly(ethylene glycol)-poly(D, L-lactide) block copolymer micelles with modulated surface charge. J Control Release. 2001;77(1-2):27-38.
10. Sheng Y, Liu C, Yuan Y, et al. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials. 2009;30(12):2340-2348.
11. Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl. 2010;49(36):6288-6308.
12. Kim YK, Minai-Tehrani A, Lee JH, Cho CS, Cho MH, Jiang Hl. Therapeutic efficiency of folated poly(ethylene glycol)-chitosan-graft-polyethylenimine-Pdcd4 complexes in H-ras12V mice with liver cancer. Int J Nanomedicine. 2013;8:1489-1498.
13. Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm. 2008;5(4):496-504.
14. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Noninvasive imaging of quantum dots in mice. Bioconjug chem. 2004;15(1):79-86.
15. Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WC. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009;9(5):1909-1915.
16. Li SD, Huang L. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim Biophys Acta. 2009;1788(10): 2259-2266.
17. Park K. To PEGylate or not to PEGylate, that is not the question. J Control Release. 2010;142(2):147-148.
18. Sun G, Hagooly A, Xu J, et al. Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles. Biomacromolecules. 2008;9(7):1997-2006.
19. Li C, Zhao X, Wang Y, et al. Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan. Int J Pharm. 2013; 443(1-2):17-25.
20. Lin X, Wang ZJ, Huang F, et al. Long-circulating delivery of bioactive polysaccharide from radix ophiopogonis by PEGylation. Int J Nanomedicine. 2011;6:2865-2872.
21. Beletsi A, Panagi Z, Avgoustakis K. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. Int J Pharm. 2005;298(1):233-241.
22. Harada A, Kataoka K. Chain length recognition: core-shell supramolecular assembly from oppositely charged block copolymers. Science. 1999;283(5398):65-67.
23. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47(1):113-131.
24. Bae Y, Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv Drug Deliv Rev. 2009;61(10):768-784.
25. Daly WH, Poche D. The preparation of n-carboxyanhydrides of alpha-amino-acids using bis (trichloromethyl) carbonate. Tetrahedron Lett. 1988;29(46):5859-5862.
26. Frank MM, Fries LF. The role of complement in inflammation and phagocytosis. Immunol Today. 1991;12(9):322-326.
27. Tanford C, Nozaki Y, Rohde MF. Size and shape of globular micelles formed in aqueous solution by n-alkylpolyoxyethylene ethers. J Phys Chem. 1977;81(16):1555-1560.
28. Uchida K, Otsuka H, Kaneko M, Kataoka K, Nagasaki Y. A reactive poly(ethylene glycol) layer to achieve specific surface plasmon resonance sensing with a high S/N ratio: the substantial role of a short underbrushed PEG layer in minimizing nonspecific adsorption. Anal Chem. 2005;77:1075-1080.
29. Brain JD, Molina RM, DeCamp MM, Warner AE. Pulmonary intravascular macrophages: their contribution to the mononuclear phagocyte system in 13 species. Am J Physiol. 1999;276(1 Pt 1):146-154.
30. Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153(3):198-205.
31. Fang C, Shi B, Pei YY, Hong MH, Wu J, Chen HZ. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci. 2006;27(1):27-36.
32. Gao H, Xiong J, Cheng T, et al. In vivo biodistribution of mixed shell micelles with tunable hydrophilic/hydrophobic surface. Biomacromolecules. 2013;14(2):460-467.